<div id="readability-page-1"><div><p>Healthcare is among the worst-performing sectors as Wall Street starts December reversing Black Friday gains.</p><p>    Citius Oncology shares climbed after the company commercially launched its treatment Lymphir for patients with a rare type of cancer that affects the skin. </p><p>    Shares of vaccine makers fall as a FDA official's memo outlined a link between COVID-19 mRNA vaccines and myocarditis deaths in 10 children. </p><p>    Eli Lilly cut prices of its Zepbound drug single-dose vials on its direct-to-consumer platform after it lowered prices of its multi-dose pens last month. </p><p>   Write to Paulo Trevisani at paulo.trevisani@wsj.com </p><p>    (END) Dow Jones Newswires</p><p>12-01-25 1659ET</p></div></div>

CTOR

<p>Healthcare stocks are underperforming as Wall Street reverses Black Friday gains. Citius Oncology shares rose after launching Lymphir for a rare skin cancer. Vaccine makers' shares fell due to an FDA memo linking COVID-19 mRNA vaccines to myocarditis deaths in children. Eli Lilly reduced prices for Zepbound drug vials on its direct-to-consumer platform.</p>

Healthcare Stocks Reverse Some Recent Gains -- Healthcare Roundup